Earnings results for Theratechnologies (NASDAQ:THTX)
Theratechnologies Inc. is expected* to report earnings on 10/13/2021 before market open. The report will be for the fiscal Quarter ending Aug 2021. The reported EPS for the same quarter last year was $-0.09.
Theratechnologies last released its earnings results on July 14th, 2021. The reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The firm earned $17.79 million during the quarter. Theratechnologies has generated ($0.30) earnings per share over the last year (($0.30) diluted earnings per share). Earnings for Theratechnologies are expected to grow in the coming year, from ($0.19) to ($0.05) per share. Theratechnologies has confirmed that its next quarterly earnings report will be published on Wednesday, October 13th, 2021.
Analyst Opinion on Theratechnologies (NASDAQ:THTX)
According to the issued ratings of 4 analysts in the last year, the consensus rating for Theratechnologies stock is Hold based on the current 3 hold ratings and 1 buy rating for THTX. The average twelve-month price target for Theratechnologies is $3.17 with a high price target of $4.50 and a low price target of $2.00.
on THTX’s analyst rating history
Dividend Strength: Theratechnologies (NASDAQ:THTX)
Theratechnologies does not currently pay a dividend. Theratechnologies does not have a long track record of dividend growth.
Insiders buying/selling: Theratechnologies (NASDAQ:THTX)
In the past three months, Theratechnologies insiders have not sold or bought any company stock. Only 19.29% of the stock of Theratechnologies is held by institutions.
Earnings and Valuation of Theratechnologies (NASDAQ:THTX
Earnings for Theratechnologies are expected to grow in the coming year, from ($0.19) to ($0.05) per share. The P/E ratio of Theratechnologies is -11.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Theratechnologies is -11.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Theratechnologies has a P/B Ratio of 87.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here